Fingerprint
Dive into the research topics of 'Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Transitioning from development to commercial: risk-based guidance for critical materials management in cell therapies
Michael Scott, Dominic Clarke, Yonatan Lipsitz, Harvey Brandwein, Julie Allickson, Dalia Alzebdeh, Sasha Aleksic, Crystal Kraft, Lexan Lhu, Kenneth Cornetta
Research output: Contribution to journal › Article › peer-review